ACADIA Pharmaceuticals Inc (ACAD)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 81,841 77,929 73,694 62,923 41,639 26,161 13,675 8,883 10,166 10,314 14,860 17,399 19,141 21,881 20,000 20,268 20,550 20,583 20,471 19,992
Payables US$ in thousands
Payables turnover

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $81,841K ÷ $—K
= —

The payables turnover ratio for ACADIA Pharmaceuticals Inc is unavailable as there is no data provided for accounts payable for the periods specified. The payables turnover ratio is calculated by dividing the cost of goods sold by the average accounts payable for a specific period. It measures how efficiently a company is managing its payables by comparing the cost of goods sold to its average accounts payable balance.

Without information on accounts payable, it is not possible to calculate or analyze the payables turnover ratio for ACADIA Pharmaceuticals Inc during the specified periods. Payables turnover is an important metric for assessing a company's liquidity and efficiency in managing its outstanding payments to suppliers. A high payables turnover ratio indicates that the company is paying its suppliers quickly, while a low ratio may suggest that the company is taking longer to settle its payables.

Therefore, the lack of data on payables turnover for ACADIA Pharmaceuticals Inc limits the ability to evaluate its efficiency in managing its accounts payable and its overall financial performance in relation to this specific aspect.